Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla., Nov. 19, ...

TAHO Pharma begins patient dosing in US phase III trial of antithrombotic oral dissolving film, TAH3311: Taipei Wednesday, November 20, 2024, 16:00 Hrs [IST] TAHO Pharmaceuticals ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

People using blood thinners to control their heart rhythm shouldn't expect the medications to head off thinking declines as ...

Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when usi ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...

Research published in the European Heart Journal shows that individuals on anticoagulant medication face twice the risk of ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...